Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Human ISG15 Recombinant Nanobody (SAA2428) (HY485023)

Anti-Human ISG15 Recombinant Nanobody (SAA2428)
Anti-Human ISG15 Recombinant Nanobody (SAA2428)
Price(USD): $
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HY485023
Description
Anti-Human ISG15 Nanobody (SAA2428) [SAA2428] (HY485023) is a alpaca monoclonal antibody detecting ISG15 in ELISA. Suitable for Human.
Species reactivityHuman
ApplicationsELISA
Host speciesAlpaca
IsotypeVHH-His
Clone IDSAA2428
Clonality Monoclonal
Target Ubiquitin-like protein ISG15, Interferon-induced 15 kDa protein, Interferon-induced 17 kDa protein, IP17, Ubiquitin cross-reactive protein, hUCRP, ISG15, G1P2, UCRP
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Purified by Nickel column.
Accession P05161
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:2000-1:20000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Ubiquitin-like protein ISG15 is a ~17 kDa protein. Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein. ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein. Its target proteins include IFIT1, MX1/MxA, PPM1B, UBE2L6, UBA7, CHMP5, CHMP2A, CHMP4B and CHMP6. Isgylation of the viral sensor IFIH1/MDA5 promotes IFIH1/MDA5 oligomerization and triggers activation of innate immunity against a range of viruses, including coronaviruses, flaviviruses and picornaviruses. Can also isgylate: EIF2AK2/PKR which results in its activation, RIGI which inhibits its function in antiviral signaling response, EIF4E2 which enhances its cap structure-binding activity and translation-inhibition activity, UBE2N and UBE2E1 which negatively regulates their activity, IRF3 which inhibits its ubiquitination and degradation and FLNB which prevents its ability to interact with the upstream activators of the JNK cascade thereby inhibiting IFNA-induced JNK signaling.

1. Kim, YJ. et al. (2016) PLoS pathogens 12, e1005850. PMID: 27564865
2. Deng, Z. et al. (2024) Bone research 12, 63. PMID: 39465252
3. Liu, G. et al. (2021) Nature microbiology 6, 467-478. PMID: 33727702
4. Swaim, CD. et al. (2017) Molecular cell 68, 581-590.e5. PMID: 29100055
Note For research use only
Images
  • Anti-Human ISG15 Recombinant Nanobody (SAA2428)

    SDS-PAGE

    SDS-PAGE for Anti-Human ISG15 Nanobody (SAA2428)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list